Rabkin R, Hirayama P, Roth R A, Frank B H
Kidney Int. 1986 Sep;30(3):348-54. doi: 10.1038/ki.1986.191.
Removal of insulin from the peritubular vessels involves binding of insulin to specific receptors in the basolateral membranes (BLM); this is followed by phosphorylation of the receptor which may mediate the actions of the hormone. In most tissues receptor number is regulated by plasma insulin levels and is increased in insulinopenic diabetics. To determine whether cortical BLM insulin receptors are similarly regulated, we studied insulin binding to receptors in BLM from normal control rats and rats with streptozotocin diabetes of varying severity. Specific binding of insulin did not differ between control and modestly insulinopenic diabetics but was increased significantly in the severely insulinopenic diabetics. Insulin treatment returned binding to normal. Scatchard analysis suggested an increase in the binding capacity of the severe diabetic BLM rather than an increase in affinity for insulin. This latter was confirmed by competitive experiments in which similar displacement curves were obtained with control and diabetic membranes. Insulin removed by glomerular filtration binds to specific receptors in the luminal membranes but unlike BLM receptors, phosphorylation of these luminal receptors has not been observed. To determine whether luminal and BLM receptors differ structurally, binding sites in both membranes were affinity labelled with 125I-insulin and the cross linking agent, disuccinimidyl suberate, and subjected to SDS-polyacrylamide gel electrophoresis in the presence of a reducing agent. Autoradiograms revealed that the major specifically labelled subunit in both membranes is a 135,000 Mr species which is more abundant in the BLM. We conclude that insulin receptors in cortical BLM respond to severe insulinopenic diabetes as do receptors in most other tissues.(ABSTRACT TRUNCATED AT 250 WORDS)
胰岛素从肾小管周围血管的移除涉及胰岛素与基底外侧膜(BLM)上特定受体的结合;随后受体发生磷酸化,这可能介导了该激素的作用。在大多数组织中,受体数量受血浆胰岛素水平调节,在胰岛素缺乏的糖尿病患者中会增加。为了确定皮质BLM胰岛素受体是否受到类似调节,我们研究了胰岛素与正常对照大鼠以及患有不同严重程度链脲佐菌素糖尿病大鼠的BLM中受体的结合情况。对照大鼠和轻度胰岛素缺乏的糖尿病大鼠之间胰岛素的特异性结合没有差异,但在严重胰岛素缺乏的糖尿病大鼠中显著增加。胰岛素治疗可使结合恢复正常。Scatchard分析表明,严重糖尿病BLM的结合能力增加,而非对胰岛素的亲和力增加。这一点在竞争性实验中得到证实,在该实验中,对照膜和糖尿病膜获得了相似的置换曲线。经肾小球滤过清除的胰岛素与管腔膜上的特定受体结合,但与BLM受体不同,尚未观察到这些管腔受体的磷酸化。为了确定管腔受体和BLM受体在结构上是否不同,用125I-胰岛素和交联剂辛二酸二琥珀酰亚胺酯对两种膜中的结合位点进行亲和标记,并在还原剂存在的情况下进行SDS-聚丙烯酰胺凝胶电泳。放射自显影片显示,两种膜中主要的特异性标记亚基是一种分子量为135,000的蛋白质,在BLM中含量更高。我们得出结论,皮质BLM中的胰岛素受体与大多数其他组织中的受体一样,对严重胰岛素缺乏性糖尿病有反应。(摘要截短至250字)